References

  1. Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Muoz A et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360(9349):1921-6. PubMed | Google Scholar

  2. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003;362(9401):2089-94. PubMed | Google Scholar

  3. Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev. 2002 Mar;4(1):27-35. PubMed | Google Scholar

  4. Hoffmann CJ, Seaberg EC, Young S, Witt MD, Acunto D, Phair J et al. Recipients. Young. 2010;23(14):1881-9. PubMed | Google Scholar

  5. Palella Jr FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. JAIDS J Acquir Immune Defic Syndr. 2006;43(1):27-34. PubMed | Google Scholar

  6. Weber, Rainer. Liver-related deaths in persons infected with the human immunodeficiency virus: The d:a:d study. Arch Intern Med. 2006 Aug;166(15):1632-41. PubMed | Google Scholar

  7. Wester CW, Bussmann H, Koethe J, Moffat C, Vermund S, Essex M et al. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. HIV Ther. 2009;3(5):501-26. PubMed | Google Scholar

  8. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005;19(6):593-601. PubMed | Google Scholar

  9. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic). JAIDS J Acquir Immune Defic Syndr. 2008 Aug;48(5):590-8. PubMed | Google Scholar

  10. WHO E. Management of hepatitis B and HIV coinfection. Copenhagen: WHO Regional Office for Europe; 2011.

  11. Joint United Nations Programme on HIV/AIDS. UNAIDS World AIDS day report 20 Geneva: UNAIDS; 2011.

  12. Burnett RJ, François G, Kew MC, Leroux-Roels G, Meheus a, Hoosen AA et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int. 2005;25(2):201-13. PubMed | Google Scholar

  13. Diop-Ndiaye H, Touré-Kane C, Etard J f, Lô G, Diaw P, Ngom-Gueye N f et al. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol. 2008 Aug;80(8):1332-6. PubMed | Google Scholar

  14. Nyirenda M, Beadsworth MBJ, Stephany P, Hart CA, Hart IJ, Munthali C et al. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect. 2008;57(1):72-7. PubMed | Google Scholar

  15. Kapembwa KC, Goldman JD, Lakhi S, Banda Y, Bowa K, Vermund SH et al. HIV, Hepatitis B, and Hepatitis C in Zambia. J Glob Infect Dis. 2011 Jul; 3(3):269-74. PubMed | Google Scholar

  16. Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M et al. Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol. 2010;48(9):3223-30. PubMed | Google Scholar

  17. Agency GN. 2011 HIV Sentinel Survey Report reveals marginal increase of pandemic. 2012. Google Scholar

  18. NACP. Guidelines for Antiretroviral. Strategies. 2010;(February 2004):208-33. PubMed | Google Scholar

  19. Chao J, Chang ET, So SK. Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC Public Health. 2010;10(1):98. PubMed | Google Scholar

  20. Samuel SO, Aderibigbe SA, Salami TAT, Babatunde OA. Health workers knowledge, attitude and behaviour towards hepatitis B infection in Southern Nigeria. Int J Med Med Sci. 2009;1(10):418-424. PubMed | Google Scholar

  21. Ghana Statistical Service. 2010 Population and Housing Census. Ghana Stat Serv [Internet]. 2012;1-117. Available from: http://www.statsghana.gov.gh/docfiles/2010phc/Census2010_Summary_report_of_final_results.pdf. Accessed on January 22, 2015.

  22. Nyonator F. Ghana Health Service Annual Report 2011. Accra: Ghana Health Service; 2012.

  23. Bierrenbach. Steps in applying Probability Proportional to Size (PPS) and calculating Basic Probability Weights. (c):1-5. Google Scholar

  24. Singh A, Masuku M. Sampling techniques & determination of sample size in applied statistics research: an overview. IjecmCoUk. 2014;II(11):1-22. PubMed | Google Scholar

  25. Israel GD. Determining Sample Size. Univ Florida, IFAS Ext [Internet]. 1992;PE0D6(April 2009):1-5.
    Available from: https://edis.ifas.ufl.edu/pdffiles/PD/PD00600.pdf. Accessed on January 22, 2015

  26. Nagu TJ, Bakari M, Matee M. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2008;8(1):416. PubMed | Google Scholar

  27. Wester CW, Bussmann H, Koethe J, Moffat C, Vermund S, Essex M et al. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. HIV Ther. 2009 Sep;3(5):501-26. PubMed | Google Scholar

  28. Blankson A, Wiredu EK, Gyasi RK, Adjei A, Tettey Y. Sero-prevalence of hepatitis B and C viruses in cir-rhosis of the liver in Accra Ghana. Ghana Med J. 2005;39(4):132-7. PubMed | Google Scholar

  29. Shimelis T, Torben W, Medhin G, Tebeje M, Andualm A, Demessie F et al. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia. Sex Transm Infect. 2008;84(1):37-41. PubMed | Google Scholar

  30. Moore E, Beadsworth MBJ, Chaponda M, Mhango B, Faragher B, Njala J et al. Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection. J Infect. 2010 Aug;61(2):155-63. PubMed | Google Scholar

  31. Braga WSM, Castilho M da C, Santos ICV dos, Moura MAS, Segurado AC. Low prevalence of hepatitis B virus, hepatitis D virus and hepatitis C virus among patients with human immunodeficiency virus or acquired immunodeficiency syndrome in the Brazilian Amazon basin. Rev Soc Bras Med Trop. 2006 Dec;39(6):519-22. PubMed | Google Scholar

  32. Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries. 2009;3(5):369-375. PubMed | Google Scholar

  33. Pereira RAR de A, Mussi ADH, Silva VC de AE, Souto FJ. Hepatitis B Virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil. BMC Infect Dis. 2006 Feb;6(1):34. PubMed | Google Scholar

  34. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer Ö, Zeynep S. Prevalence of Hepatitis B Infection in the Southeastern Region of Turkey?. comparison of risk factors for HBV infection in rural and urban areas. 2005;(7):15-9. PubMed | Google Scholar

  35. Reid SR. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J. 2009 Aug;6(1):24. PubMed | Google Scholar

  36. Irving A. An ancient practice: Scarification and tribal marking in Ghana. Indep Study Proj Collect Connect Coll [Internet]. 2007; Paper 127. Available from: http://digitalcollections.sit.edu/isp_collection/127. Accessed on January 22, 2015.

  37. Ziraba AK, Bwogi J, Namale A, Wainaina CW, Mayanja-Kizza H. Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. BMC Infect Dis. 2010 Jun;10(1):191. PubMed | Google Scholar

 

 

 

 

 

 

 

 

<